Caplin Point Laboratories has informed that the Board of Directors, at its meeting held today, has approved the following: Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023; Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend; Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2023 along with Auditors Report (Annexure - 2). It also enclosed a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4); Further the Nomination and Remuneration Committee of the Board of Directors of the Company, has allotted 12,000 equity shares of face value Rs. 2 each, to the employees of the Company, upon exercise of stock options under Employee Stock Options Scheme(s) of the Company.
The above information is a part of company’s filings submitted to BSE.
